Related Experiment Video
Updated: May 29, 2026
06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
Hematologic changes in visceral leishmaniasis/kala azar
Summary
Visceral Leishmaniasis (VL), or Kala Azar, is a parasitic disease causing significant hematologic issues like anemia. Prompt treatment leads to rapid hematologic improvement, with rare relapses and no increased long-term cancer risk.
Area of Science:
- Hematology
- Infectious Diseases
- Parasitology
Background:
- Visceral Leishmaniasis (VL), also known as Kala Azar, is a chronic parasitic infection caused by the Leishmania donovani complex.
- It is endemic in the Indian subcontinent, particularly in Bihar and West Bengal.
- VL presents with diverse hematologic manifestations, often leading patients to seek hematological consultation before diagnosis.
Purpose of the Study:
- To outline the spectrum of hematologic manifestations in Visceral Leishmaniasis.
- To describe the hematologic response to treatment and long-term outcomes.
- To inform hematologists about VL as a differential diagnosis for unexplained hematologic abnormalities.
Main Methods:
- Review of clinical presentations and laboratory findings in VL patients.
- Analysis of hematologic parameters including anemia, leucopenia, thrombocytopenia, and pancytopenia.
- Monitoring of hematologic recovery during and after treatment.
Main Results:
- Anemia is the most frequent hematologic finding in VL.
- Other potential hematologic issues include leucopenia, thrombocytopenia, pancytopenia, hemophagocytosis, and disseminated intravascular coagulation.
- Hematologic improvement is observed within one week of treatment, with complete response in 4-6 weeks.
Conclusions:
- Visceral Leishmaniasis presents with a wide range of hematologic abnormalities, with anemia being most common.
- Prompt treatment of VL results in significant and rapid hematologic recovery.
- Long-term follow-up indicates rare relapses and no increased risk of hematolymphoid malignancies.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...